US2017369555A1PendingUtilityA1
Artificial antibody polypeptides
Assignee: RESEARCH CORPORATION TECH INCPriority: Jul 11, 2000Filed: Feb 16, 2016Published: Dec 28, 2017
Est. expiryJul 11, 2020(expired)· nominal 20-yr term from priority
Inventors:Shohei Koide
C12N 15/1044C12N 15/1037C07K 14/78G01N 33/6845C07K 16/00C40B 30/04C07K 2317/565
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides a fibronectin type III (Fn3) molecule, wherein the Fn3 contains a stabilizing mutation. The present invention also provides Fn3 polypeptide monobodies, nucleic acid molecules encoding monobodies, and variegated nucleic acid libraries encoding such monobodies. Also provided are methods of preparing a Fn3 polypeptide monobody, and kits to perform the methods.
Claims
exact text as granted — not AI-modified1 - 21 . (canceled)
22 . A method of preparing a fibronectin type III (Fn3) polypeptide monobody comprising the steps of:
a) providing a DNA sequence encoding a plurality of Fn3 β-strand domain sequences that are linked to a plurality of loop region sequences, wherein at least one loop region contains a unique restriction enzyme site, and wherein at least one of the plurality of Fn3 β-strand domain sequences are more stable at neutral pH than wild-type Fn3; b) cleaving the DNA sequence at the unique restriction site; c) inserting into the restriction site a DNA segment known to encode a peptide capable of binding to a specific binding partner (SBP) or a transition state analog compound (TSAC) so as to yield a DNA molecule comprising the insertion and the DNA sequence of (a); and d) expressing the DNA molecule so as to yield polypeptide monobody.
23 . A method of preparing a fibronectin type III (Fn3) polypeptide monobody comprising the steps of:
(a) providing a replicatable DNA sequence encoding a plurality of Fn3 β-strand domain sequences that are linked to a plurality of loop region sequences, wherein the nucleotide sequence of at least one loop region is known, and wherein at least one of the plurality of Fn3 β-strand domain sequences are more stable at neutral pH than wild-type Fn3; (b) preparing polymerase chain reaction (PCR) primers sufficiently complementary to the known loop sequence so as to be hybridizable under PCR conditions, wherein at least one of the primers contains a modified nucleic acid sequence to be inserted into the DNA; (c) performing polymerase chain reaction using the DNA sequence of (a) and the primers of (b); (d) annealing and extending the reaction products of (c) so as to yield a DNA product; and (e) expressing the polypeptide monobody encoded by the DNA product of (d).
24 . A method of preparing a fibronectin type Ill (Fn3) polypeptide monobody comprising the steps of:
a) providing a replicatable DNA sequence encoding a plurality of Fn3 β-strand domain sequences that are linked to a plurality of loop region sequences, wherein the nucleotide sequence of at least one loop region is known, and wherein at least one of the plurality of Fn3 β-strand domain sequences are more stable at neutral pH than wild-type Fn3; b) performing site-directed mutagenesis of at least one loop region so as to create a DNA sequence comprising an insertion mutation; and c) expressing the polypeptide monobody encoded by the DNA sequence comprising the insertion mutation.
25 - 50 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.